Company Information
CIN
Status
Date of Incorporation
08 January 1996
State / ROC
Hyderabad / ROC Hyderabad
Last Balance Sheet
31 March 2021
Last Annual Meeting
29 September 2021
Paid Up Capital
85,011,050
Authorised Capital
291,000,000
Directors
Venkatanaga Kali Vara Prasada Raju Vetukuri
Director/Designated Partner
about 2 years ago
about 2 years ago
Pankaj Bhuneshwar Patwari
Director/Designated Partner
about 2 years ago
about 2 years ago
Shweta Jalan
Director/Designated Partner
about 2 years ago
about 2 years ago
Jayant Bhalchandra Manmadkar
Director/Designated Partner
over 2 years ago
over 2 years ago
Anil Kumar Chanana
Director/Designated Partner
almost 4 years ago
almost 4 years ago
Abhijit Mangalmoy Mukherjee
Director/Designated Partner
about 5 years ago
about 5 years ago
Bhaskar Vemban Iyer
Director/Designated Partner
about 5 years ago
about 5 years ago
Jayesh Tulsidas Merchant
Director
about 5 years ago
about 5 years ago
Nicola Neeladri
Director
about 5 years ago
about 5 years ago
Anand Surana
Managing Director
over 5 years ago
over 5 years ago
Sirish Kumar Ravula
Director
over 5 years ago
over 5 years ago
Venkatasubbarao Potluri
Director
over 5 years ago
over 5 years ago
Anandkumar Gupta
Director
about 11 years ago
about 11 years ago
Ravi Kumar Yerra
Director
about 20 years ago
about 20 years ago
Rajender Juvvadi Rao
Managing Director
over 22 years ago
over 22 years ago
Past Directors
Ashok Kumar Jain
Director
about 5 years ago
about 5 years ago
Ashwani Kumar Malhotra
Whole Time Director
over 5 years ago
over 5 years ago
Vivekanand Thutupalli
Director
about 7 years ago
about 7 years ago
Divyang Bipinchandra Kapadia
Director
about 8 years ago
about 8 years ago
Vijayakrishna Thirumaleswara Konila
Nominee Director
almost 9 years ago
almost 9 years ago
Subhash .
Company Secretary
over 9 years ago
over 9 years ago
Jayakumar Ramamoorthy
Director
almost 11 years ago
almost 11 years ago
Pritam Singh
Nominee Director
about 20 years ago
about 20 years ago
Srinivasa Reddy Battula
Director
almost 22 years ago
almost 22 years ago
Patents
An improved process for the preparation of Metaxalone, wherein reacting 3,5-dimethyl phenol with 3-chloro-l,2-propane diol in presence of a base; isolating 3-(3,5-dimethylphenoxy) propane- 1,2-diol; reacting 3-(3,5-dimethylphenoxy)propane-l,2-diol with urea in presence of polyalkylene glycol to obtain Metaxalone; op...
The present invention relates to an improved process for the preparation of Entacapone (!) of formula (I).
comprising of knoevenagal condensation of 3,4-dihydroxy-5-nitrobenzaldehyde of formula (II)
with N, N-diethyl cyanoacetamide of formula (III)
in an aprotic non-polar solvent, containing catalytic amount of a...
The present invention relates to one pot synthesis of Fexofenadine starting from the l-acetoxy-2-methyl-2-phenyl. propane or l-acetoxy-2-methyl-2-[4-[4-chloro-1-oxy-butyl)phenyl]-propane, without isolating the intermediates to obtain Fexofenadine, which is optionally converted to the pharmaceutically acceptable salt...
The sustained release compositions comprising Nitazoxanide and/or its pharmaceutically acceptable salts thereof.
A pharmaceutical composition comprising Milnacipran or its pharmaceutically acceptable salts and a superdisintegrant in amount of 0.1% to 50%, preferably 2% to 20% by weight of the composition.
The present invention relates to novel polymorph of Agomelatine and a process for the preparation thereof
The present invention relates to a pharmaceutical composition comprising Orlistat including its salts, solvates, polymorphs, racemic mixtures, enantiomers, and mixtures thereof and a process for preparing the formulation and their methods of use with at least one pharmaceutically acceptable excipient, which is devoi...
A process for the preparation of Solifenacin composition comprising the steps of: a) dispersing the Solifenacin or its pharmaceutically acceptable salts thereof into the solvent; b) preparing a dry blend by mixing pharmaceutically acceptable excipients; c) adding the granulating fluid to the dry blend to obtain gran...
The present invention relates to a pharmaceutical composition comprising Tamsulosin and its pharmaceutically acceptable salts thereof. The present invention specifically relates to controlled release pharmaceutical composition comprising Tamsulosin having formula-I and a process for the preparation thereof.
...
A pharmaceutical composition comprising an uncoated immediate release dosage form comprising Tianeptine and its pharmaceutically acceptable salts.
1) A novel process for the preparation of compound of formula VI:
wherein, Rjand R2 represents Hydrogen, Cito C4 alkyl, benzyl, Substituted benzyl, reacting the compound of Formula-IV with chlorinating agent to yield compound of formula V;
which is further reacted with toluene to obtain the compound of formula VI,...
A pharmaceutical composition comprising a high drug load of Fenofibrate, wherein the Fenofibrate is present in more than 70% by weight of total composition.
The invention relates to Ferric organic compound containing compositions. The pharmaceutical compositions of the invention which include Ferric citrate as the active ingredient, a disintegrant, and one or more pharmaceutically acceptable excipients
The invention relates to oral pharmaceutical compositions of ferric citrate comprising dry granulation, wherein ferric citrate is combined with dry binder or disintegrant, and a lubricant, which is roller compacted, and then mixed with extra granular material comprising disintegrant, and lubricant, wherein the amoun...
The present invention relates to an improved process for the preparation of highly pure Propiomazine Maleate of formula-I.
One Pot Synthesis Of 4 (1,2 Dihydro 2 Oxobenzo[D]Imidazol 3 Yl)butanoic Acid, A Key Intermediate For
The present invention relates to one pot process for the preparation of 4-(l,2-dihydro-2-oxobenzo[d]imidazol-3-yl)butanoic acid of Formula-1, which is a key intermediate and its use in the preparation of Zilpaterol, which comprises condensation of methyl-4-chloro butyrate with 1-(prop-l-en-2-yl)-lH-benzo[d]iirudazol...
An improved process for preparation of ferric citrate, wherein the process involves reacting ferric salt with ammonium hydroxide to adjust the pH to 7.2 to 7.8 at a temperature of 25-35°c to form ferric hydroxide, which is then added citric acid at a temperature of 75-85°c to yield ferric citrate in solution and a...
Charges
23 September 2019
Indusind Bank Ltd.
18 Crore
05 May 2018
Icici Bank Limited
20 Crore
30 January 2018
Indusind Bank Ltd.
20 Crore
30 January 2018
Indusind Bank Ltd.
10 Crore
04 October 2017
Axis Bank Limited
8 Lak
23 June 2017
Axis Bank Limited
44 Lak
16 April 2012
Axis Bank Limited
21 Lak
17 December 2011
State Bank Of India
135 Crore
27 June 2013
State Bank Of India
22 Crore
06 January 2015
Icici Bank Limited
24 Crore
30 January 2018
Indusind Bank Ltd.
27 Crore
11 September 2006
Icici Bank Limited
4 Crore
17 November 2007
State Bank Of India
4 Crore
22 November 2000
State Bank Of India
3 Crore
27 June 2013
State Bank Of India
22 Crore
27 March 2010
State Bank Of India
30 Crore
09 August 2011
State Bank Of India
78 Crore
11 June 2010
Bank Of Bahrain And Kuwait Bsc
2 Crore
18 March 2010
Yes Bank Limited
3 Crore
18 June 2008
3i Infotech Trusteeship Services Limited
9 Crore
29 September 2006
Icici Bank Limited
2 Crore
15 April 2010
Srei Equipment Finance Private Limited
19 Lak
03 February 2004
Axis Bank
14 Crore
11 June 2003
Uti Bank Ltd
4 Crore
28 July 2004
Uti Bank Ltd
3 Crore
29 October 2005
Andhra Pradesh State Financial Corporation
9 Crore
29 October 2010
Barclays Bank Plc
8 Crore
17 December 2005
Uti Bank Ltd.
45 Lak
13 March 2020
Axis Bank Limited
52 Crore
29 July 2021
Sbicap Trustee Company Limited
155 Crore
27 March 2010
State Bank Of India
0
28 July 2004
Uti Bank Ltd
0
22 November 2000
State Bank Of India
0
03 February 2004
Axis Bank
0
11 June 2003
Uti Bank Ltd
0
06 January 2015
Icici Bank Limited
0
27 June 2013
State Bank Of India
0
27 June 2013
State Bank Of India
0
16 April 2012
Axis Bank Limited
0
09 August 2011
State Bank Of India
0
29 October 2010
Barclays Bank Plc
0
29 September 2006
Icici Bank Limited
0
17 December 2005
Uti Bank Ltd.
0
11 September 2006
Icici Bank Limited
0
17 November 2007
State Bank Of India
0
18 June 2008
3i Infotech Trusteeship Services Limited
0
15 April 2010
Srei Equipment Finance Private Limited
0
18 March 2010
Yes Bank Limited
0
29 October 2005
Andhra Pradesh State Financial Corporation
0
11 June 2010
Bank Of Bahrain And Kuwait Bsc
0
17 December 2011
State Bank Of India
0
30 July 2014
State Bank Of India
0
30 January 2018
Others
0
17 December 2011
State Bank Of India
0
25 July 2018
Others
0
23 June 2017
Axis Bank Limited
0
30 January 2018
Others
0
30 January 2018
Others
0
04 October 2017
Axis Bank Limited
0
13 March 2020
Axis Bank Limited
0
30 January 2018
Others
0
27 March 2010
State Bank Of India
0
28 July 2004
Uti Bank Ltd
0
22 November 2000
State Bank Of India
0
03 February 2004
Axis Bank
0
11 June 2003
Uti Bank Ltd
0
06 January 2015
Icici Bank Limited
0
27 June 2013
State Bank Of India
0
27 June 2013
State Bank Of India
0
16 April 2012
Axis Bank Limited
0
09 August 2011
State Bank Of India
0
29 October 2010
Barclays Bank Plc
0
29 September 2006
Icici Bank Limited
0
17 December 2005
Uti Bank Ltd.
0
11 September 2006
Icici Bank Limited
0
17 November 2007
State Bank Of India
0
18 June 2008
3i Infotech Trusteeship Services Limited
0
15 April 2010
Srei Equipment Finance Private Limited
0
18 March 2010
Yes Bank Limited
0
29 October 2005
Andhra Pradesh State Financial Corporation
0
11 June 2010
Bank Of Bahrain And Kuwait Bsc
0
17 December 2011
State Bank Of India
0
30 July 2014
State Bank Of India
0
30 January 2018
Others
0
17 December 2011
State Bank Of India
0
25 July 2018
Others
0
23 June 2017
Axis Bank Limited
0
30 January 2018
Others
0
30 January 2018
Others
0
04 October 2017
Axis Bank Limited
0
13 March 2020
Axis Bank Limited
0
30 January 2018
Others
0
